Ascorbic acid 150 mg / ferrous sulfate 60 mg Extended Release Oral Tablet [Vitelle Irospan]
RxNorm 260509
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 260509 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ascorbic acid 150 mg / ferrous sulfate 60 mg Extended Release Oral Tablet [Vitelle Irospan].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Ascorbic acid 150 mg / ferrous sulfate 60 mg Extended Release Oral Tablet [Vitelle Irospan]
(Atom ID: 12370258)
SY
Synonym (SY):
Vit-C 150 mg / FESO4 60 mg Extended Release Oral Tablet [Vitelle Irospan]
(Atom ID: 6358096)
SY
Synonym (SY):
Vitamin C 150 mg / FESO4 60 mg Extended Release Oral Tablet [Vitelle Irospan]
(Atom ID: 6356440)
SY
Synonym (SY):
Vitelle Irospan (ascorbic acid 150 mg / ferrous sulfate 60 mg) Extended Release Oral Tablet
(Atom ID: 6357445)
SY